Navidence
Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research
UndisclosedSeed
Role not disclosedGV
Grand Ventures
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Grand Ventures is the investment firm named in Navidence and Comp AI financing coverage, with Comp AI identifying it as co-lead.
Recorded funding activity
Comp AI automates compliance evidence, control monitoring and vendor-risk work. Navidence supplies computable disease and outcome definitions for real-world evidence research. The two financings retain their different customers and participant roles.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share